Search by Drug Name or NDC

    NDC 45802-0736-84 clindamycin phosphate and benzoyl peroxide 50; 10 mg/g; mg/g Details

    clindamycin phosphate and benzoyl peroxide 50; 10 mg/g; mg/g

    clindamycin phosphate and benzoyl peroxide is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE.

    Product Information

    NDC 45802-0736
    Product ID 45802-736_4934962f-c507-4b32-9196-dded1e01eed1
    Associated GPIs 90059902594020
    GCN Sequence Number 062456
    GCN Sequence Number Description clindamycin phos/benzoyl perox GEL (GRAM) 1.2(1)%-5% TOPICAL
    HIC3 L5H
    HIC3 Description ACNE AGENTS,TOPICAL
    GCN 98232
    HICL Sequence Number 017263
    HICL Sequence Number Description CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE
    Brand/Generic Generic
    Proprietary Name clindamycin phosphate and benzoyl peroxide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clindamycin, Benzoyl Peroxide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GEL
    Route TOPICAL
    Active Ingredient Strength 50; 10
    Active Ingredient Units mg/g; mg/g
    Substance Name BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090979
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0736-84 (45802073684)

    NDC Package Code 45802-736-84
    Billing NDC 45802073684
    Package 1 TUBE in 1 CARTON (45802-736-84) / 45 g in 1 TUBE
    Marketing Start Date 2012-06-26
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.58613
    Pricing Unit GM
    Effective Date 2024-02-21
    NDC Description CLIND PH-BENZOYL PEROX 1.2-5%
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis